Barclays PLC Rockwell Medical, Inc. Transaction History
Barclays PLC
- $357 Billion
- Q4 2024
A detailed history of Barclays PLC transactions in Rockwell Medical, Inc. stock. As of the latest transaction made, Barclays PLC holds 28,854 shares of RMTI stock, worth $37,798. This represents 0.0% of its overall portfolio holdings.
Number of Shares
28,854
Previous 22,625
27.53%
Holding current value
$37,798
Previous $90,000
34.44%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding RMTI
# of Institutions
62Shares Held
8.25MCall Options Held
226KPut Options Held
78.2K-
Armistice Capital, LLC New York, NY3.04MShares$3.99 Million0.09% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.2MShares$1.58 Million0.0% of portfolio
-
Globeflex Capital L P San Diego, CA743KShares$973,6650.13% of portfolio
-
Marshall Wace, LLP London, X0596KShares$781,2300.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny442KShares$579,4780.0% of portfolio
About ROCKWELL MEDICAL, INC.
- Ticker RMTI
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 10,675,200
- Market Cap $14M
- Description
- Rockwell Medical, Inc., together with its subsidiaries, operates as a biopharmaceutical company that targets end-stage renal disease and chronic kidney disease with therapies and products for the treatment of iron deficiency and hemodialysis in the United States and internationally. The company offers Triferic Dialysate and Triferic AVNU, an iro...